Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

NIH Director's Transformative Research Award (R01 Clinical Trial Optional)

Active

Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The NIH Director's Transformative Research Award, managed by the National Institutes of Health under the Department of Health and Human Services, provides funding for individual scientists and research teams engaged in bold and unconventional research. This initiative is part of the NIH Common Fund's High-Risk, High-Reward Research Program and aims to support projects that can establish new scientific paradigms, create transformative technologies, or develop innovative clinical approaches. This specific opportunity is listed as a forecast with a posted date of September 3, 2026, and is categorized as an R01 award where clinical trials are optional. Interested parties can contact the NIH Director's Transformative Research Award Program via email for further information.

General Info

NIH funding for bold, unconventional research via R01 awards for scientists and teams.

Agency

Department Of Health And Human Services → National Institutes Of Health

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedSep 3

forecast

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health

Office AddressUSA

Contacts

NIH Director's Transformative Research Award Program

contact@example.gov

Full Description

Show more

The NIH Director's Transformative Research Award supports individual scientists and research teams pursuing bold, groundbreaking, and unconventional research with the potential to transform science, create new scientific paradigms, establish new clinical approaches, or develop transformative technologies. The Transformative Research Award is part of the NIH Common Fund's High-Risk, High-Reward Research Program.

Similar Contracts

Same NAICS industry code

Machine Learning & Predictive Analytics EngineeringThis subcontract, titled Machine Learning and Predictive Analytics Engineering, is issued by the Naval Air Systems Command under the Department of Defense. The project focuses on the development and deployment of production-ready machine learning algorithms to support prime contractors on F-35 Joint Program Office projects. Key objectives include creating solutions for supply-chain optimization, readiness forecasting, and predictive maintenance, utilizing ML engineering pipelines within AWS and Azure GovCloud architectures. The scope of work involves managing CI/CD/CT pipelines and delivering validated source code and predictive models. Due to the nature of the work, an active Top Secret clearance is required. The performance location for this contract is Arlington, Virginia, with a response deadline set for November 10, 2026.

Naval Air Systems Command

POSTED

about 23 hours ago

DEADLINE

Digital Biomarker & Computational Modeling DevelopmentThis subcontract focuses on the development and validation of objective digital biomarkers and computational models to support prime contractors within the Defense Health Agency Alzheimer’s Research Program. The scope of work involves utilizing high-performance computing and AI/ML software frameworks to create algorithms for early disease detection and predictive models for disease forecasting. The project requires strict adherence to HIPAA compliance and FDA software validation standards to ensure the integrity and security of the delivered models. Performance will take place in Frederick, Maryland, with the primary objective of delivering validated digital biomarkers and predictive tools to the Department of Defense.

Defense Health Agency

POSTED

about 23 hours ago

DEADLINE

in about 1 month

TBI & Psychological Health Research Services

Defense Health Agency

POSTED

about 23 hours ago

DEADLINE

in about 1 month

Pharmacology and Pain Subject Matter Expert (SME)

Omas Strategic Buying Center - Professional Services

POSTED

about 23 hours ago

DEADLINE

Novel Materials Analysis SupportThe Novel Materials Analysis Support subcontract involves providing specialized research and analysis to characterize, detect, and quantify materials of interest for prime contractors supporting Air Force Technical Applications Center projects. The scope of work includes investigating research and development technologies to improve detection methods and utilizing chemical analysis tools and specialized hardware to quantify novel materials. The successful provider will be responsible for delivering detailed analysis reports and quantification data. This effort is managed under the Department of Defense for the agency FA7022 Amic Det 2 Ol Patrick Pka, with performance taking place at Patrick Air Force Base. Due to the sensitive nature of the work, a TS/SCI security clearance is required. The opportunity is categorized under NAICS code 541715, with a response deadline set for November 14, 2026.

FA7022 Amic Det 2 Ol Patrick Pka

POSTED

about 23 hours ago

DEADLINE

Analytical Laboratory R&D (Methods & Technology)The Analytical Laboratory R&D (Methods & Technology) subcontract focuses on the development and testing of new analytical methods and technologies to improve the forensic analysis of field samples for Air Force Technical Applications Center projects. The scope of work involves performing research, development, test, and evaluation to concentrate target compounds from complex matrices, conducting extensive literature searches, and evaluating new analytical instrumentation. These tasks require the use of advanced laboratory tools and forensic instrumentation to deliver finalized analytical protocols and equipment evaluations. This Department of Defense project is managed by the Amic Det 2 Ol Patrick Pka and is performed at Patrick Air Force Base. Due to the nature of the forensic and technical work, a TS/SCI security clearance may be required for personnel. The opportunity is categorized under NAICS code 541715, with a response deadline set for November 14, 2026.

FA7022 Amic Det 2 Ol Patrick Pka

POSTED

about 23 hours ago

DEADLINE

Chemical Process Modeling & Simulation (ChemCAD)This subcontract for the Department of Defense involves the research, development, and maintenance of chemical process models to support prime contractors on Air Force Technical Applications Center projects. The scope of work focuses on developing and updating ChemCAD models, enhancing software for thermodynamics and emission methodology, and conducting RDT&E to determine chemical manufacture constraints. Successful execution requires the use of ChemCAD software and specialized thermodynamic databases, with final deliverables consisting of technical reports and updated software models. The project is managed by the Department of Defense under agency FA7022 Amic Det 2 Ol Patrick Pka and will be performed at Patrick Air Force Base. Due to the sensitive nature of the work, a Top Secret security clearance is mandatory for personnel. Interested parties should note the response deadline of November 14, 2026, and the classification under NAICS code 541715.

FA7022 Amic Det 2 Ol Patrick Pka

POSTED

about 23 hours ago

DEADLINE

Ammonia-Assisted Regeneration for Longer-Lasting Direct Air Capture (DAC)

Solicitation # S-167699

Triad - DOE Contractor

POSTED

about 23 hours ago

DEADLINE

Space Power and Reactor Capabilities (SPARC) - Sources Sought Notice

Solicitation # 80GRC026R0009_PS

NASA Glenn Research Center

POSTED

about 23 hours ago

DEADLINE

Atomically Precise Molecules (APM)

Solicitation # DARPA-PS-26-141

The Atomically Precise Molecules (APM) program, solicitation DARPA-PS-26-141, is a 36-month initiative by the DARPA Multi X Office seeking innovative synthesis techniques for programmable precision polymers (PPPs) and nonlinear optical (NLO) materials. The program aims to develop scalable materials with strictly controlled monomer sequences and compositions, culminating in a prototype NLO material integrated into a government-provided electro-optic modulator capable of achieving greater than 1THz modulation. The effort is structured in two phases, with Phase I lasting 12 months and focusing on synthesis capabilities. Research limited to inorganic materials or incremental improvements to existing state-of-the-art practices is specifically excluded. Awards will be issued as Other Transaction for Prototype Agreements, with payments processed through the Wide Area Workflow system based on a schedule of milestones. Proposals are due by December 18, 2026, via the Broad Agency Announcement Tool and must include technical, management, and pricing volumes. Eligibility is restricted to U.S. organizations, and all performers must comply with CMMC Level 2 self-certification and NIST SP 800-171 standards for safeguarding Controlled Unclassified Information. Evaluation will be based on technical approach, relevance to the DARPA mission, budget realism, and the capability to transition the technology to military or commercial sectors.

Defense Advanced Research Projects Agcy

POSTED

about 23 hours ago

DEADLINE

in about 2 months

Sole Source to L3Harris ForceX, Inc | VAMPIRE Spares

Solicitation # SPRRA2-27-R-SP05

The Defense Logistics Agency (DLA) is issuing a sole-source solicitation, SPRRA2-27-R-SP05, to L3Harris ForceX, Inc. for the procurement of spares essential to the production of the U.S. Army's Vehicle Agnostic Modular Palletized ISR Rocket Equipment (VAMPIRE) Stalker Weapon Systems. This requirement will be integrated into the existing Subsumable Contract, SPRRA2-25-D-0007, supporting the Portfolio Acquisition Executive (PAE) FIRES Integrated Fires Mission Command (IFMC) Project Office. The acquisition includes a wide array of components such as pallet assemblies, MX-10 RSTA sensors, COFIN and PDB assemblies, FANG box assemblies, EchoShield radars, and various ruggedized computers and cable harnesses. The government seeks firm-fixed, best price/quantity break range pricing for these items. L3Harris ForceX must submit a comprehensive proposal by November 30, 2026, including a summary schedule, detailed cost data in Microsoft Excel format, and a proposal adequacy checklist for offers exceeding the TINA threshold. Key compliance requirements include JCP Certification for export-controlled items, disclosure of any organizational conflicts of interest per FAR 9.5, and a value-added description if subcontracting exceeds 70 percent of the total cost of work. The contract is subject to FAR and DFARS regulations regarding covered telecommunications equipment and pass-through charges.

Al DLA Aviation At Huntsville

POSTED

about 23 hours ago

DEADLINE

in about 1 month

A-- TREDS III supporting DOE, NNSA and NFO

Solicitation # 89233127RNA000340

Nnsa Non-Mo Cntrctng Operations Division

POSTED

about 23 hours ago

DEADLINE

More opportunities from Department Of Health And Human Services → National Institutes Of Health

Same awarding agency

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource-Constrained Settings--Implementation Science Network (PATC3H-IN)The Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network (PATC3H-IN) is a National Institutes of Health initiative focused on conducting implementation science research to combat adolescent HIV. By developing and testing scalable, low-resource care delivery models in low- and middle-income countries, the network aims to generate robust evidence on HIV incidence, prevention uptake, and viral suppression. These international studies leverage large adolescent populations and innovative, cost-effective service delivery methods to create practice-ready strategies that can be adapted for marginalized and high-burden populations within the United States. The program addresses critical gaps in the U.S. healthcare system where adolescents face similar barriers to care as those in resource-constrained global settings, including poverty, stigma, and fragmented services. Comprising Clinical Research Centers and a Data and Coordinating Center, PATC3H-IN supports the goals of the Ending the HIV Epidemic in the U.S. initiative by accelerating the translation of resilient and cost-conscious care models into domestic practice. This effort is authorized under the Eunice Kennedy Shriver National Institute of Child Health and Human Development to improve overall care outcomes and prevent new HIV acquisitions among at-risk youth.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

CAPSTONE Centers for Multidisciplinary Research in Child Abuse and NeglectThe CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect is a forecast opportunity from the National Institutes of Health under the Department of Health and Human Services. This initiative focuses on child sexual abuse as a critical public health issue, aiming to overcome ethical and methodological barriers to better understand and prevent its lifelong developmental and health consequences. The program emphasizes translational research to create measurable public health impacts rather than solely identifying risk factors. The initiative utilizes a collaborative P50 mechanism to establish national resources for high-quality research. Key areas of focus include evaluating intervention efficacy, conducting longitudinal studies on chronic disease outcomes, researching biological embedding, and improving data infrastructure. The program is managed by the Pediatric Trauma and Critical Illness Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Learning Disabilities Research CentersThe National Institutes of Health, through the Eunice Kennedy Shriver National Institute of Child Health and Human Development, is forecasting an opportunity to support transdisciplinary research centers dedicated to improving outcomes for children and youth with specific learning disabilities in mathematics, reading, and writing. These centers will prioritize enhancing the identification and classification of these disabilities while exploring their genetic and neurobiological foundations and testing innovative screening and intervention methods. Beyond primary research, the funded centers are expected to leverage their infrastructure to collaborate with key stakeholders and provide project-based mentorship for emerging researchers in the field of learning disabilities. This initiative is authorized under several sections of the U.S. Code to advance the understanding and treatment of these developmental challenges.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Discovery Gateway to Reproductive Health InnovationThe National Institutes of Health, through the Eunice Kennedy Shriver National Institute of Child Health and Human Development, intends to establish the Discovery Gateway to Reproductive Health Innovation. This initiative aims to create a comprehensive, open-access web-based visualization platform and knowledgebase to advance research on male and female reproductive health issues, including infertility, uterine fibroids, endometriosis, preeclampsia, and preterm birth. By integrating multi-omic, pharmacogenomic, and clinical data, the Gateway seeks to fill critical knowledge gaps and provide the biomedical community with shared infrastructure to identify biomarkers, drug targets, and disease mechanisms. The primary objective of this project is to catalyze the discovery of new treatments and cures while fostering public-private partnerships and the development of commercial products. This effort aligns with recommendations from the Task Force on Research Specific to Pregnant Women and Lactating Women. The opportunity is currently listed as a forecast, with administrative oversight provided by the Obstetric and Pediatric Pharmacology and Therapeutics Branch.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)The National Institutes of Health is seeking applicants to establish Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications. These centers will provide essential resources and testing services to the biomedical community to advance the development of genome editing technologies for treating human diseases. By collaborating with NIH-funded investigators, the centers will evaluate the efficacy and safety of delivery technologies, establish editing thresholds to minimize off-target effects, and determine feasibility within various model systems. The initiative emphasizes the creation of in vivo and in vitro research models, with a specific interest in new approach methodologies and human-biology-based models to complement traditional methods. Testing Centers are expected to develop standardized assays and operating procedures to ensure scientific rigor and reproducibility. While focusing on a limited number of initial projects, these centers will build adaptable core systems designed to support a wide range of diseases and offer fee-for-service resources on a local, regional, and national scale.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

DEADLINE

Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs)The National Institute on Aging, under the Department of Health and Human Services, intends to publish a Notice of Funding Opportunity for the Coordinating Center of the Claude D. Pepper Older Americans Independence Centers program. This center will act as a facilitator for site interactions and translate program objectives and findings for scientific and general audiences. The selected entity must possess significant scientific expertise in geriatrics and a proven track record of coordinating complex multi-site projects. This announcement serves as a forecast to allow potential applicants time to establish collaborations before the official solicitation is released. The funding opportunity will utilize the U24 activity code. Interested investigators with expertise in aging research are encouraged to prepare for the upcoming application process.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Program (U19 Clinical Trial Optional)The National Institute on Alcohol Abuse and Alcoholism, under the Department of Health and Human Services, intends to issue a Notice of Funding Opportunity to continue the Collaborative Initiative on Fetal Alcohol Spectrum Disorders. This multidisciplinary research consortium focuses on a wide range of studies, including basic, clinical, translational, diagnostic, intervention, and prevention research aimed at addressing the lifelong physical, cognitive, and behavioral impairments caused by prenatal alcohol exposure. The program seeks to support high-priority needs such as improving early identification and diagnosis, validating interventions, and exploring the mechanisms of alcohol teratogenesis to reduce the incidence of these disorders. Successful projects must demonstrate strong integration with the broader consortium through the use of shared resources, coordinated data activities, and multidisciplinary expertise. This forecast indicates a research program where clinical trials are optional.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Centers for Research on Neglected Infectious DiseasesThe National Institute of Allergy and Infectious Diseases, under the National Institutes of Health, is establishing the Centers for Research on Neglected Infectious Diseases to combat communicable viral, bacterial, parasitic, and fungal infections. This initiative focuses on the epidemiology, pathogenesis, diagnosis, treatment, and prevention of parasitic neglected infectious diseases within endemic regions. By building sustainable in-country research capacity and expertise, the program aims to identify, contain, and mitigate these diseases at their source to protect global health and reduce the risk of spread within the United States. This opportunity is issued as a forecast by the Department of Health and Human Services and is governed by the Public Health Service Act and Federal Regulations 42 CFR Part 52 and 2 CFR Part 200. Interested parties can coordinate with the Division of Microbiology and Infectious Diseases for further information. The program emphasizes a multidisciplinary approach to research and training to address the substantial morbidity and mortality associated with understudied infectious diseases.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)The National Institutes of Health, under the Department of Health and Human Services, is offering a Phased Innovation Award to advance innovative HIV prevention interventions. This funding opportunity utilizes a two-stage R61/R33 structure to move research from initial development and feasibility testing to larger-scale efficacy and implementation studies. The initial R61 phase focuses on the development, refinement, and pilot testing of novel strategies to address critical scientific and operational questions, ensuring readiness for expanded evaluation across diverse populations. Upon the successful completion of R61 milestones, the R33 phase provides support for expanded testing of interventions and implementation strategies. These studies may evaluate the scalability, sustainability, and clinical management of HIV prevention interventions, specifically including integrated approaches that address alcohol use and related comorbidities. Interested parties can contact the HIV/AIDS and Alcohol Research Program for further information.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)The National Institutes of Health is forecasting a Notice of Funding Opportunity to solicit applications for early to definitive clinical trials. This initiative seeks proposals testing a wide range of interventions, including drugs, devices, biologics, procedures, and behavioral or social interventions, provided they align with the research missions of the participating NIH Institutes, Centers, and Offices. The funding will utilize a bi-phasic, milestone-driven R61/R33 activity code with a maximum project period of seven years. The R61 phase focuses on planning activities, while the R33 phase supports the actual clinical trial. Although applications are not currently being accepted, this notice serves as an advance alert for investigators with expertise in trial design, implementation, and stakeholder engagement to begin developing collaborations and projects.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Continuation of the Exceptional Longevity Data Management and Coordinating Center (EL DMCC) (U24 Clinical Trial Not Allowed)The National Institute on Aging intends to issue a single U24 cooperative agreement award to support the continued operation and expansion of the Exceptional Longevity Data Management and Coordinating Center. Serving as the central hub for human longevity translational research, the center integrates deeply phenotyped cohorts and multi-omics datasets to enable cross-cohort analyses and collaborative research. Key responsibilities include data harmonization, the implementation of common data standards, and the management of the ELITE Portal, which provides the research community with secure access to analytical tools and cloud-based computational workspaces. The upcoming funding opportunity will require the Coordinating Center to expand its capabilities in artificial intelligence, machine learning, and the integration of diverse datasets across different species. Future objectives include the development of curated target knowledgebases for therapeutic targets, the enhancement of portal interoperability according to FAIR data principles, and the strengthening of community engagement through specialized training and workshops. This notice serves as a forecast to allow potential applicants to establish collaborations before the official solicitation is released.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

Immune Drivers of Autoimmune DiseaseThe National Institute of Allergy and Infectious Diseases seeks to support the Immune Drivers of Autoimmune Disease network to investigate the triggers and early mechanisms of autoimmunity in humans. The primary goal is to develop tools for risk prediction and staging, identify pre-clinical immune mechanisms, and utilize artificial intelligence and big data to prevent autoimmune diseases. This initiative emphasizes the creation of preclinical cohorts and the use of remote recruitment and sampling to advance medical research. The network will be managed by a Coordinating Center responsible for data harmonization, sample sharing, and the administration of an Infrastructure Opportunity Fund for collaborative research projects. This forecast, issued by the National Institutes of Health under the Department of Health and Human Services, establishes a framework for shared infrastructure and steering committee oversight to identify common pathways and prevention opportunities.

Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 1 month ago

DEADLINE

Earlier notices in this NAICS code

Posted before this notice, open and closed

YELL - 14185 - North Entrance Road Revegetation Services

POSTED

about 2 months ago

DEADLINE

Riverside University Health System Behavioral Health (RUHS-BH) Rustin Wall and Structural Analysis Project

Solicitation # FM08410015357

Riverside County

POSTED

about 2 months ago

DEADLINE

NIOSH Mentored Research Scientist Development Award (K01)

Centers For Disease Control And Prevention

POSTED

about 2 months ago

DEADLINE

LIPTM00397 - CANES Engineering IPT - IWRP 25-LANT-2814 (C)

POSTED

about 2 months ago

DEADLINE

LIPTM00448-New Task Order Award under contract N6523618D8001-RobZickau-(Northrop Grumman-New)

POSTED

about 2 months ago

DEADLINE

Shipboard Advanced Tactical Data Link (ATDL) Engineering Support (C)

POSTED

about 2 months ago

DEADLINE

APPROVAL OF KUBO GROUP (KUBO)S EXCEPTIONAL METHD FOR ANALYZING THE DESIGN OF A HEATED GREENHOUSE IN SANTA MARIA, CALIFORNIA

Energy Commission

POSTED

DEADLINE

Cost, Energy and Indoor Air Quality Impacts of Cooking Technology & Ventilation Choices in California Homes: The CEVICA Follow-On Study

Solicitation # EPC-26-006

Energy Commission

POSTED

DEADLINE

Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional)

National Institutes Of Health

POSTED

DEADLINE

AOI VI: Multi-Domain Communications & Cyber Operations

POSTED

DEADLINE

ATC ENG, TECH and OPERATIONAL Total SYS SPT Follow on (C)

POSTED

DEADLINE

N660012491003 Modification P0000X

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS